Bharat Immunological & Biologicals Corporation Ltd. - Research Center
524663 BIBCL Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 62.17 | -9.14 | -22.71 | -12.50 | -5.68 |
| Loan funds | |||||
| Secured loans | 77.89 | 27.29 | 3.04 | - | - |
| Unsecured loans | - | - | - | 32.22 | - |
| Total | 183.24 | 61.33 | 23.51 | 62.90 | 37.50 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 125.72 | 45.66 | 5.97 | 5.97 | 5.94 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 41.64 | 41.43 | 1.50 | 1.27 | 0.99 |
| Net block | 84.08 | 4.23 | 4.47 | 4.70 | 4.95 |
| Capital work-in-progress | 31.90 | 31.90 | 0.22 | 0.22 | 0.22 |
| Investments | - | - | - | - | - |
| Net current assets | |||||
| Current assets, loans & advances | 96.75 | 67.86 | 122.15 | 120.04 | 48.23 |
| Less : current liabilities & provisions | 29.49 | 42.65 | 103.32 | 62.06 | 15.91 |
| Total net current assets | 67.26 | 25.21 | 18.83 | 57.98 | 32.32 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 183.24 | 61.33 | 23.51 | 62.90 | 37.50 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 0.04 | 0.04 | 0.04 | 0.66 | 3.96 |
| Number of equity sharesoutstanding (Lacs) | 431.80 | 431.80 | 431.80 | 431.80 | 431.80 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis